How It's Diagnosed Many can live a normal life with this thickening of heart muscle, but it can cause cardiac arrest, too. How can a doctor tell if you have it? Working With Your Care Team The more you know abou
How is hypertrophic cardiomyopathy diagnosed? How is cauda equina syndrome treated? How is Rett syndrome different from autism? How is a degenerative disease diagnosed? How prominent is neurodegenerative disease? How is mast cell activation syndrome diagnosed?
How is stress cardiomyopathy diagnosed?Stress Cardiomyopathy:It refers to a type of cardiomyopathy that is caused by stress. It can be caused by emotional or physical stress, but it is more common in people who are going through emotional trauma. It has been observed in people who have gone ...
Barry J. Maron MD DirectorThe Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, MN, USALisa Salberg PresidentHypertrophic Cardiomyopathy Association, Hibernia, NJ, USABlackwell Publishing
How rare is eosinophilic esophagitis? Is peptic ulcer disease relieved by eating? Is a hiatal hernia deadly? How common is silent celiac disease? How is gastroesophageal reflux disease treated? Is GERD a hereditary disease? How is hypertrophic cardiomyopathy diagnosed?
Fabry disease (FD) is a treatable cause of hypertrophic cardiomyopathy (HCM). We aimed to determine the independent predictors of FD and to define a clinically useful strategy to discriminate FD among HCM. Methods Multicenter study including 780 patients with the ESC definition of HCM. FD screenin...
developing a way for nurses to monitor a hospital patient’s movements in bed so if a patient is about to fall, nurses can get to that patient before it happens; and using AI to learn more about cardiac arrest events caused by a symptom known as hypertrophic cardiomyop...
We present the case of a 16-year-old male pediatric patient diagnosed with hypertrophic cardiomyopathy (HCM, identified as having a high risk of sudden cardiac death (SCD), who underwent a successful subcutaneous implantable cardiac defibrillator (S-ICD) implantation as a primary prevention measure ...
This is another key point determining the cancer progression and has enormous importance for monitoring of cancer development. This shift is usually diagnosed by the downregulation of epithelial markers like E-cadherin and the upregulation of mesenchymal markers like N-cadherin and vimentin on cells [...
Among them, 312 patients (29.2%) had IHD, 88 (8.2%) dilated cardiomyopathy (DCM), 78 (7.3%) hypertrophiccardiomyopathy (HCM), 25 (2.3%) cardiac sarcoidosis, and 18 (1.7%) arrhythmogenic right ventricular cardiomyopathy. However, approximately 40% of the patients diagnosed with idiopathic VT ...